Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (309)
- Scheduling (national classification system) (165)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
580 result(s) found, displaying 201 to 225
-
Scheduling decisions (final)Notification of amendments to the Poisons Standard in relation to Delegate-only final decisions and New Chemical Entities (NCEs), September 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 32, 22 March 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 33, 20 May 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 15 September 2022
-
Meeting statementsMeeting statement from meeting 7 of the Medical Devices Action Plan Consumer Working Group (MDCWG).
-
Meeting statementsA meeting statement from the fourth meeting of the Dental Sector Working Group is now available.
-
Corporate reportsThe report has been published, including MTP Connect's major findings and TGA's proposed response to the major recommendations.
-
Corporate reportsPrescription opioid tracking research
-
Scheduling decisions (final)Notification of final decisions in relation to matters considered at ACMS #36, ACCS #32 and Joint ACMS-ACCS #29 (November 2021).
-
Scheduling decisions (final)Final decision on proposed amendments to the Poisons Standard relating to isothiazolinones, methylisothiazolinone and methylchloroisothiazolinone
-
Meeting statementsA meeting statement from the third meeting of the Dental Sector Working Group is now available.
-
Meeting statementsMeeting statement from meeting 5 of the Medical Devices Consumer Working Group (MDCWG).
-
Meeting statementsMeeting statement from meeting 6 of the Medical Devices Consumer Working Group (MDCWG).
-
Scheduling decisions (final)Notification of amendments to the Poisons Standard in relation to Delegate-only final decisions and New Chemical Entities (NCEs), April 2022
-
Meeting statementsTherapeutic Goods Advertising Consultative Committee, 21 March 2022 communique
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 31, 8 February 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 30, 14 January 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 29, 7 January 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
Corporate reportsPrescription opioid tracking research
-
TGA laboratory testing reportsTest results of compliance testing against TGO110 of available and imported nicotine vaping products are now published on the TGA website.
-
Corporate reportsMedicines Safety Update - Information for health professionals
-
Scheduling decisions (final)Public notice - Delegate-only decisions to amend the Poisons Standard and New Chemical Entities (NCEs)